comparemela.com

Latest Breaking News On - Ian chau - Page 1 : comparemela.com

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

United-states
Japan
South-korea
Taiwan
American
Pushkar-mutha
Mariat-bourlon
Tycel-jovelle-phillips
Tony-mok
Lin-wang
Peter-robert-galle
Charlene-mantia

First-Line Nivolumab Plus Chemotherapy Shows Real-World Efficacy in Gastric/GEJ/Esophageal Cancers

Real-world findings demonstrated a favorable survival benefit with nivolumab plus chemotherapy in advanced gastroesophageal adenocarcinoma.

San-francisco
California
United-states
Ian-chau
Flatiron-health
Royal-marsden
Cancers-symposium
Nivolumab
Chemotherapy
Dvanced-or-metastatic-gastric-cancer
Gastroesophageal-junction-cancer
R-esophageal-adenocarcinoma

Adding Opdivo to Frontline Chemo Boosts Survival in Advanced GI Cancers

Patients with advanced gastric cancers tended to have better survival outcomes when given Opdivo plus chemotherapy, compared to those who were given chemotherapy alone.

Ian-chau
Flatiron-health
Frontline-opdivo
Royal-marsden
News
Gastric-cancers
Asco-gi
Opdivo
Survival

Gratitude activities held in An Giang and Thai Nguyen provinces

PANO - A delegation from the Central Military Commission, the Ministry of National Defense, led by Deputy Director of the General Department of Political Affairs (GDP) Major General Nguyen Van Gau offered incense at An Giang provincial war cemetery and presented gifts to policy beneficiaries and a former GDP deputy chief on December 17 in An Giang

Vietnam
Republic-of
Ian-chau
Tinh-bac-giang
An-giang
Chau-thanh
Phú
Dinh-hoa
Bì-duong
Thai-nguyen
Thánguyêvm
Vietnamese

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.